PURPOSE: The aim of the present study was to assess the efficacy of transjugular intrahepatic portosystemic shunts (TIPS) in 45 patients with cirrhosis during a mean follow-up of 7 months. METHODS: Forty-five consecutive patients treated by TIPS and who had been followed for at least 6 months after TIPS or until death, were included. Mean follow-up was 7.2 +/- 5.0 months. Shunt patency was assessed at 1 week and 1 month, then every 3 months after the procedure by Doppler US and angiography whenever needed. RESULTS: Thirty-six patients had been stented for refractory bleeding from ruptured esophagogastric varices. Of these, 8 patients (22%) rebled, 7 of whom were treated by a second shunt. Nine patients were treated for refractory ascites. Three patients had recurrent ascites due to shunt obstruction. All were treated by a second shunt which occluded in 2 patients. As a whole, 14 (31.1%) patients developed shunt obstruction within a mean of 120 +/- 136 days, 4 of whom remained asymptomatic. Other complications were septicemia by Staphylococcus aureus in 1 patient, transient encephalopathy in 9 patients, and disseminated intravascular coagulation in 1 patient. CONCLUSIONS: TIPS appears to be a relatively safe and effective technique in treating complications of portal hypertension in patients with cirrhosis. Shunt obstruction in 31% of our patients probably represents the most important limitation of this technique.
PURPOSE: The aim of the present study was to assess the efficacy of transjugular intrahepatic portosystemic shunts (TIPS) in 45 patients with cirrhosis during a mean follow-up of 7 months. METHODS: Forty-five consecutive patients treated by TIPS and who had been followed for at least 6 months after TIPS or until death, were included. Mean follow-up was 7.2 +/- 5.0 months. Shunt patency was assessed at 1 week and 1 month, then every 3 months after the procedure by Doppler US and angiography whenever needed. RESULTS: Thirty-six patients had been stented for refractory bleeding from ruptured esophagogastric varices. Of these, 8 patients (22%) rebled, 7 of whom were treated by a second shunt. Nine patients were treated for refractory ascites. Three patients had recurrent ascites due to shunt obstruction. All were treated by a second shunt which occluded in 2 patients. As a whole, 14 (31.1%) patients developed shunt obstruction within a mean of 120 +/- 136 days, 4 of whom remained asymptomatic. Other complications were septicemia by Staphylococcus aureus in 1 patient, transient encephalopathy in 9 patients, and disseminated intravascular coagulation in 1 patient. CONCLUSIONS: TIPS appears to be a relatively safe and effective technique in treating complications of portal hypertension in patients with cirrhosis. Shunt obstruction in 31% of our patients probably represents the most important limitation of this technique.
Authors: H Rousseau; J Puel; F Joffre; U Sigwart; C Duboucher; C Imbert; C Knight; L Kropf; H Wallsten Journal: Radiology Date: 1987-09 Impact factor: 11.105
Authors: R F Colapinto; R D Stronell; M Gildiner; A C Ritchie; B Langer; B R Taylor; L M Blendis Journal: AJR Am J Roentgenol Date: 1983-04 Impact factor: 3.959
Authors: J M LaBerge; L D Ferrell; E J Ring; R L Gordon; J R Lake; J P Roberts; N L Ascher Journal: J Vasc Interv Radiol Date: 1991-11 Impact factor: 3.464
Authors: G M Richter; G Noeldge; J C Palmaz; M Roessle; V Slegerstetter; M Franke; W Gerok; W Wenz; E Farthman Journal: Radiology Date: 1990-03 Impact factor: 11.105
Authors: Geert Maleux; Frederik Nevens; Alexander Wilmer; Sam Heye; Chris Verslype; Maria Thijs; Guy Wilms Journal: Eur Radiol Date: 2004-06-25 Impact factor: 5.315